4.6 Article

Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?

Petra A. Custers et al.

Summary: This study aimed to assess the clinical and oncological outcomes of stage IV rectal cancer patients who underwent the watch-and-wait approach following radiotherapy. The results showed that the watch-and-wait approach can help avoid total mesorectal excision and permanent colostomy in the majority of patients, despite a relatively high regrowth rate.

COLORECTAL DISEASE (2022)

Article Oncology

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Julio Garcia-Aguilar et al.

Summary: This study demonstrates that organ preservation is achievable in patients with locally advanced rectal cancer treated with total neoadjuvant therapy, without a decrease in survival.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer et al.

Summary: The RAPIDO trial aimed to reduce systemic relapses in locally advanced rectal cancer through short-course radiotherapy, chemotherapy, and delayed surgery. Results showed a decreased probability of disease-related treatment failure in the experimental group compared to standard care, with diarrhea being the most common adverse event and neurological toxicity being prominent in the standard care group during adjuvant chemotherapy.

LANCET ONCOLOGY (2021)

Article Oncology

Interpreting the RAPIDO trial: factors to consider

Rob Glynne-Jones

LANCET ONCOLOGY (2021)

Article Oncology

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy et al.

Summary: In patients with cT3 or cT4 M0 rectal cancer, intensifying chemotherapy with FOLFIRINOX before preoperative chemoradiotherapy significantly improved disease-free survival outcomes and reduced neurotoxicity. Thus, the PRODIGE 23 results have the potential to impact clinical practice.

LANCET ONCOLOGY (2021)

Review Gastroenterology & Hepatology

Neoadjuvant Pelvic Radiotherapy in the Management of Rectal Cancer with Synchronous Liver Metastases: Is It Worth It?

Maitham A. Moslim et al.

Summary: This review examines the role of pelvic radiotherapy and chemoradiation in the setting of treatable metastatic liver disease by reporting landmark randomized controlled trials. Radiotherapy is commonly used in metastatic rectal cancer treatment but limited data calls for further randomized trials to explore optimal treatment strategies.

JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Gastroenterology & Hepatology

The Liver-First Approach for Patients with Locally Advanced Rectal Cancer and Synchronous Liver Metastases

Cornelis Verhoef et al.

DISEASES OF THE COLON & RECTUM (2009)

Article Medicine, General & Internal

Chemotherapy with preoperative radiotherapy in rectal cancer

Jean-Francois Bosset et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer

E Kapiteijn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)